Back
Larimar Therapeutics Stock Predictions
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
LRMR
Larimar Therapeutics
Last Price:
6.70
Seasonality Move:
-3.23%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Larimar Therapeutics Stock Forecast
- Over the next 52 weeks, Larimar Therapeutics has on average historically risen by 21.7% based on the past 10 years of stock performance.
- Larimar Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Larimar Therapeutics Stock Undervalued?
The current Larimar Therapeutics [LRMR] share price is $7.20. The Score for LRMR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. - LRMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Larimar Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Larimar Therapeutics has on average historically risen by 21.7% based on the past 10 years of stock performance.
Larimar Therapeutics Stock Rating
Sell
41
Larimar Therapeutics (LRMR)
is a Sell
Is Larimar Therapeutics overpriced?
- Larimar Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Larimar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
larimartx.com
52-Week Data
52-Week High:
13.68
52-Week Low:
2.18
Prediction Charts
Market Cap:
459.41M
Price in USD:
7.20
Volume:
541.9K
Beta:
0.59
Technical Analysis
SMA50:
8.35
SMA100:
8.10
SMA200:
7.45
52-Wk Change:
79.78%
Stock Predictions
-
Is Larimar Therapeutics stock public?
Yes, Larimar Therapeutics is a publicly traded company. -
What is the Larimar Therapeutics stock quote today?
The Larimar Therapeutics stock price is 7.20 USD today. -
How to buy Larimar Therapeutics stock online?
You can buy Larimar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-26 | 7.94 | 7.99 | 8.10 | 7.86 |
| Aug-27 | 8.02 | 8.06 | 8.09 | 7.79 |
| Aug-28 | 8.00 | 7.97 | 8.06 | 7.80 |
| Aug-29 | 8.06 | 8.05 | 8.28 | 8.01 |
| Aug-30 | 8.06 | 7.91 | 8.17 | 7.82 |
| Sep-3 | 7.80 | 6.94 | 7.86 | 6.77 |
| Sep-4 | 7.03 | 7.77 | 7.88 | 6.69 |
| Sep-5 | 7.70 | 8.90 | 9.03 | 7.67 |
| Sep-6 | 8.92 | 8.05 | 9.18 | 7.51 |
| Sep-9 | 8.05 | 7.55 | 8.21 | 7.49 |
| Sep-10 | 7.59 | 7.89 | 8.09 | 7.35 |
| Sep-11 | 7.85 | 7.48 | 8.03 | 7.20 |
| Sep-12 | 7.58 | 7.24 | 7.95 | 7.20 |
| Sep-13 | 7.25 | 7.20 | 7.63 | 7.02 |
Larimar Therapeutics Earnings
Larimar Therapeutics Earnings Report: Per Share Larimar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Larimar Therapeutics Forecast Revenue Growth
Larimar Therapeutics Stock Analysis: Historical quarterly revenues per share for Larimar Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.69 per share, and a decrease next year of $0.43 per share.
* Larimar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.